[go: up one dir, main page]

DE60006026D1 - Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte - Google Patents

Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte

Info

Publication number
DE60006026D1
DE60006026D1 DE60006026T DE60006026T DE60006026D1 DE 60006026 D1 DE60006026 D1 DE 60006026D1 DE 60006026 T DE60006026 T DE 60006026T DE 60006026 T DE60006026 T DE 60006026T DE 60006026 D1 DE60006026 D1 DE 60006026D1
Authority
DE
Germany
Prior art keywords
indacenes
cyclopentyl
dihydro
ethyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60006026T
Other languages
English (en)
Other versions
DE60006026T2 (de
Inventor
Frank John Urban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60006026D1 publication Critical patent/DE60006026D1/de
Publication of DE60006026T2 publication Critical patent/DE60006026T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60006026T 1999-04-30 2000-04-07 Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte Expired - Fee Related DE60006026T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13194999P 1999-04-30 1999-04-30
US131949P 1999-04-30

Publications (2)

Publication Number Publication Date
DE60006026D1 true DE60006026D1 (de) 2003-11-27
DE60006026T2 DE60006026T2 (de) 2004-06-17

Family

ID=22451736

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60006026T Expired - Fee Related DE60006026T2 (de) 1999-04-30 2000-04-07 Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte
DE60015819T Expired - Fee Related DE60015819T2 (de) 1999-04-30 2000-04-07 Pyrazolopyridinon als Zwischenprodukt

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60015819T Expired - Fee Related DE60015819T2 (de) 1999-04-30 2000-04-07 Pyrazolopyridinon als Zwischenprodukt

Country Status (24)

Country Link
US (1) US6326495B2 (de)
EP (1) EP1048667B1 (de)
JP (1) JP3510560B2 (de)
KR (1) KR100346619B1 (de)
CN (2) CN1160353C (de)
AR (1) AR029450A1 (de)
AT (2) ATE282039T1 (de)
AU (1) AU761391B2 (de)
BR (1) BR0002070A (de)
CA (1) CA2307080C (de)
DE (2) DE60006026T2 (de)
DK (2) DK1048667T3 (de)
ES (2) ES2232805T3 (de)
HU (1) HUP0001700A3 (de)
ID (1) ID25705A (de)
IL (1) IL135809A0 (de)
IN (1) IN192746B (de)
MX (1) MXPA00004214A (de)
PL (1) PL339985A1 (de)
PT (2) PT1380585E (de)
RU (1) RU2189985C2 (de)
TR (1) TR200001161A2 (de)
TW (1) TWI256392B (de)
ZA (1) ZA200002057B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148239A (en) 2009-08-13 2013-03-29 China Petroleum & Chemical A catalyst component for olefin polymerization and a catalyst comprising the same
BR112013005689A2 (pt) 2010-09-08 2016-05-03 Sumitomo Chemical Co método para produção de compostos de piridazinona e intermediário dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1094303A1 (ru) * 1982-12-24 1987-12-30 Институт физико-органической химии и углехимии АН УССР 3-Трифторметил-7-метилимидазо- @ 4,5-с @ -1,2,4-триазоло @ 4,3-а @ пиридин,обладающий спазмолитическим действием
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
NZ266525A (en) 1993-07-06 1997-10-24 Pfizer 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine derivatives and medicaments
KR970707124A (ko) 1994-10-20 1997-12-01 스피겔 알렌 제이 비사이클릭 테트라하이드로 피라졸로피리딘 및 약제로서 이의 용도(bicyclic tetrahydro pyrazolopyridines and their use as medicaments)
JP3107827B2 (ja) 1995-06-06 2000-11-13 ファイザー・インコーポレーテッド トリサイクリック5,6−ジヒドロ−9H−ピラゾロ[3,4−c]−1,2,4−トリアゾロ[4,3−a]ピリジン類

Also Published As

Publication number Publication date
KR20010029673A (ko) 2001-04-06
DE60015819T2 (de) 2005-12-08
EP1048667A1 (de) 2000-11-02
HK1031881A1 (en) 2001-06-29
ATE252582T1 (de) 2003-11-15
HUP0001700A3 (en) 2001-05-28
CN1249064C (zh) 2006-04-05
ID25705A (id) 2000-11-02
ATE282039T1 (de) 2004-11-15
TWI256392B (en) 2006-06-11
TR200001161A2 (tr) 2000-12-21
RU2189985C2 (ru) 2002-09-27
CN1478779A (zh) 2004-03-03
DE60006026T2 (de) 2004-06-17
AU3018000A (en) 2000-11-02
MXPA00004214A (es) 2002-03-08
DE60015819D1 (de) 2004-12-16
EP1048667B1 (de) 2003-10-22
AU761391B2 (en) 2003-06-05
PT1048667E (pt) 2004-03-31
IN192746B (de) 2004-05-15
HK1062678A1 (zh) 2004-11-19
JP3510560B2 (ja) 2004-03-29
PL339985A1 (en) 2000-11-06
CA2307080C (en) 2003-12-23
BR0002070A (pt) 2000-10-31
HUP0001700A2 (en) 2001-03-28
ZA200002057B (en) 2001-10-26
DK1048667T3 (da) 2004-03-01
PT1380585E (pt) 2005-03-31
ES2232805T3 (es) 2005-06-01
CN1274724A (zh) 2000-11-29
US20010039347A1 (en) 2001-11-08
AR029450A1 (es) 2003-07-02
ES2207464T3 (es) 2004-06-01
DK1380585T3 (da) 2005-03-07
JP2000344771A (ja) 2000-12-12
KR100346619B1 (ko) 2002-07-26
US6326495B2 (en) 2001-12-04
HU0001700D0 (en) 2000-07-28
CN1160353C (zh) 2004-08-04
IL135809A0 (en) 2001-05-20
CA2307080A1 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69906389D1 (de) Verfahren zur herstellung von citalopram
DE69930540D1 (de) Verfahren zur herstellung von silalkylen-siloxancopolymeren
DE69912174D1 (de) Verfahren zur Herstellung von Dialkanolaminen
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE59808528D1 (de) Verfahren zur Herstellung von 3-Glycidyloxypropyltrialkoxysilanen
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE69708271D1 (de) Verfahren zur Herstellung von Benzolderivaten
DE69922440D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 2,3-Pyridindicarboxylatderivaten
DE69805887D1 (de) Verfahren zur Herstellung von alpha-Bromolactamderivaten
DE69935355D1 (de) Verfahren zur Herstellung von Citalopram
DE69936449D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE60031231D1 (de) Verfahren zur Herstellung von 2-Alkyl-4-Isothiazolin-3-onen
DE60017330D1 (de) Verfahren zur Herstellung von 3-pyridylsulphonylpyrazolo[4,3-d]pyrimidin-7-one und Zwischenprodukte
DE69902120D1 (de) Verfahren zur Herstellung von Acetylenderivaten
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE69810718D1 (de) Verfahren zur Herstellung von Benzoxazinen
DE60004119D1 (de) Verfahren zur Herstellung von Pentaacetyl-beta-D-Glucopyranose
DE60019763D1 (de) Verfahren zur herstellung von thiazolderivaten
DE59902434D1 (de) Verfahren zur Herstellung von Isochroman-3-onen
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE50003603D1 (de) Verfahren zur Herstellung von Bistrifluormethylbenzylaminen
DE59905059D1 (de) Verfahren zur Herstellung von Hydroxyethylcyclohexanen und Hydroxyethylpiperidinen
DE69920003D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE69804920D1 (de) Verfahren zur Herstellung von Furopyridin-Derivaten und Zwischenprodukten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee